High-Dose Mitotane-Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma. (Record no. 27841396)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01384 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517190134.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201909s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1549-490X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1634/theoncologist.2017-0426 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Pape, Elise |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190912 |
| 245 00 - TITLE STATEMENT | |
| Title | High-Dose Mitotane-Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The oncologist |
| Date of publication, distribution, etc. | 03 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 389-390 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Case Reports; Letter |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adrenal Cortex Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adrenocortical Carcinoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Hormonal |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Brain Diseases |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Monitoring |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mitotane |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Feliu, Catherine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yéléhé-Okouma, Mélissa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Colling, Natacha |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Djerada, Zoubir |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gambier, Nicolas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Weryha, Georges |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Scala-Bertola, Julien |
| 773 0# - HOST ITEM ENTRY | |
| Title | The oncologist |
| Related parts | vol. 23 |
| -- | no. 3 |
| -- | p. 389-390 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1634/theoncologist.2017-0426">https://doi.org/10.1634/theoncologist.2017-0426</a> |
| Public note | Available from publisher's website |
No items available.